Revenio Group OyjREVXF 82 EV-to-FCF is 18.81 as of Jul. 05, 2026, which is 65% below its 10-year median of 53.12. GuruFocus rates REVXF with a GF Score™ of 82/100 and a GF Value™ of $40.45 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Revenio Group Oyj ranks better than 58.27% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Revenio Group Oyj's Enterprise Value is $389.2 Mil.
Revenio Group Oyj's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $20.7 Mil. Therefore, Revenio Group Oyj's EV-to-FCF for today is 18.81.
The historical rank and industry rank for Revenio Group Oyj's EV-to-FCF or its related term are showing as below:
REVXF'
s EV-to-FCF Range Over the Past 10 Years
Min: 17.29 Med: 53.12 Max: 118.95
Current: 19.67
During the past 13 years, the highest EV-to-FCF of Revenio Group Oyj was 118.95. The lowest was 17.29. And the median was 53.12.
REVXF's EV-to-FCF is ranked better than 58.27% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.4
vs REVXF: 19.67
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Revenio Group Oyj (OTCPK:REVXF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Revenio Group Oyj's PE Ratio (TTM) for today is calculated as:
Revenio Group Oyj's share price for today is $16.41.
Revenio Group Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.687.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Revenio Group Oyj EV-to-FCF Related Terms
Revenio Group Oyj EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Revenio Group Oyj's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Revenio Group Oyj's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's EV-to-FCF falls into.
Revenio Group Oyj's current Enterprise Value is $389.2 Mil.
Revenio Group Oyj's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $20.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenio Group Oyj (REVXF) has a EV-to-FCF of 18.81 as of Jul. 05, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Revenio Group Oyj and its competitors. This is 65% below median its historical median of 53.12. Over the past decade, Revenio Group Oyj's EV-to-FCF has ranged from 17.29 to 118.95. According to the industry distribution chart, Revenio Group Oyj ranks #174 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 41.7%.
Is Revenio Group Oyj's EV-to-FCF too high?
Revenio Group Oyj's current EV-to-FCF of 18.81 is 65% below median its 10-year median of 53.12. Over the past 10 years, this metric has ranged from a low of 17.29 to a high of 118.95. The Medical Devices & Instruments industry median EV-to-FCF is 23.40. Revenio Group Oyj's value of 18.81 is 19.6% below this industry median. Based on the distribution chart, Revenio Group Oyj ranks #174 out of 417 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Revenio Group Oyj has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #174 out of 417 companies for EV-to-FCF. This puts Revenio Group Oyj in the upper half of its industry. The industry median EV-to-FCF is 23.40. Revenio Group Oyj's value of 18.81 is 19.6% below this benchmark. Historically, Revenio Group Oyj's own EV-to-FCF has ranged from 17.29 to 118.95 over the past decade. While the company's 10-year median is 53.12 vs. the industry median of 23.40, Revenio Group Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.40, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Revenio Group Oyj's current EV-to-FCF of 18.81 is 19.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current EV-to-FCF is 18.81, which is 65% below median its own 10-year median of 53.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (REVXF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.45, compared to a current price of $16.41 — trading 59.4% below its estimated fair value. The current EV-to-FCF is 18.81, which is 65% below median its 10-year median of 53.12 and 19.6% below the Medical Devices & Instruments industry median of 23.40. Revenio Group Oyj's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Revenio Group Oyj (REVXF), the current EV-to-FCF is 18.81 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revenio Group Oyj (REVXF) Overvalued in 2026?
Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued.
The current stock price of $16.41 is trading 59.4% below its estimated GF Value™ of $40.45.
GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.
Key valuation signals for REVXF:
EV-to-FCF: 18.81 (65% below median its 10-year median of 53.12)
GF Value™: $40.45 vs. price of $16.41 (59.4% below fair value)
Industry Position: 19.6% below the Medical Devices & Instruments median (#174 of 417)
No single metric tells the full story. See the REVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
82GF Score
Get the complete analysis for REVXF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
REVXF has been successfully added to your 
